The In Silico Modeling and Simulation Conference to Enable Healthcare Innovation
29 - 30 March, 2022
| Online Event
Conference Day Two: Pharmaceuticals
9:00 am - 10:00 am
EST
The Executive Vision
Prith Banerjee -
Chief Technology Officer,
Ansys
Birendra David - Vice President, Delivery Manager-Inhalation and Head- Process Engineering, Dr. Reddy's Laboratories
Jean-Marie Geoffroy - VP Global Parenteral Products Development, Pfizer
Pharmaceutical and biopharmaceutical companies of all sizes across the world are adopting in silico methods, and executives from Pfizer and Dr. Reddy's Laboratories and will explain the importance of deploying Computer Modeling & Simulation (CM&S) and paint their vision for the ongoing digitalization of pharmaceutical R&D and manufacturing activities.
Birendra David
Vice President, Delivery Manager-Inhalation and Head- Process EngineeringDr. Reddy's Laboratories
10:00 am - 11:00 am
EST
The Engineering Achievements
Ross Kenyon -
P.E., Associate Director - Modeling, Simulation and Analysis,
Regeneron Pharmaceuticals, Inc.
Adrian Funke - Head of CMC Predictive Development, Bayer Pharmaceuticals
Hossam Metwally - Principal Engineer, Ansys
Digitalization of the drug manufacturing process is more than a vision. It is now a daily routine that technical leaders from Regeneron and Bayer will illustrate with concrete examples, sharing their vision for engineering simulation.
Ross Kenyon
P.E., Associate Director - Modeling, Simulation and AnalysisRegeneron Pharmaceuticals, Inc.
11:00 am - 12:30 pm
EST
The Process to Adopt and Deploy
Prith Banerjee -
Chief Technology Officer,
Ansys
Thierry Marchal - Program Director, Healthcare Solutions, Ansys
Pablo Rolandi - Executive Director, Amgen
Jan Schrooten - Co-Founder & CEO, Antleron
Liesbet Geris - Executive Director, Virtual Physiological Human Institute (VPHi)
The importance of adopting in silico methods has become obvious, and pharmaceutical leaders are looking for the most efficient ways to adopt this technology quickly while minimizing risk and uncertainty. In silico veterans, including executives from Amgen, CEO of startup company Antleron, technical leaders from Ansys, and an academic thought leader will discuss the importance of an ecosystem and their recommendations for the successful adoption of CM&S during this prestigious panel discussion chaired by Ansys CTO, Prith Banerjee.
